Introduction {#sec1}
============

A novel influenza A virus, subtype H1N1 of swine-lineage (H1N1 swl) has circulated throughout the world rapidly.[@bib1] In mass gathering places, such as, hospital outpatient units, airport quarantine facilities, and public health centers, prior to definite diagnosis, rapid screening of infection is urgently needed during the epidemic season of a novel influenza.[@bib2] In order to conduct fast screening of people with infections, such as pandemic influenza, severe acute respiratory syndrome (SARS),[@bib3] or other emerging infectious diseases, we have developed a non-contact screening system to perform human medical inspections within several tens of seconds, from non-contact derived heart and respiratory rates, as well as facial temperature measured by a non-contact method. A number of countries have applied thermography at international airports in order to detect infectious passengers. A previous study revealed that the positive predictive value (PPV) varied from 3.5% to 65.4%.[@bib4] This low PPV indicates the limited effectiveness of thermography in detecting early-stage influenza symptoms.

As a result of infection, not only body temperature but also heart and respiratory rates increase. Therefore, in order to achieve more accurate screening, heart and respiratory rates are used as new parameters for screening. We conducted non-contact influenza screening within 30 s using the newly developed screening system. The system is operated by the screening program through a linear discriminant analysis using non-contact derived variables, i.e., palmar pulse determined using a laser Doppler blood-flow meter, respiration rate determined using a 10-GHz microwave radar, and average facial temperature measured by thermography. We have previously demonstrated the possibility of non-contact determination of exposure to toxic conditions via a 1215-MHz microwave radar,[@bib5], [@bib6] which has been investigated for use in locating human subjects buried under earthquake rubble,[@bib7], [@bib8], [@bib9] in order to prevent secondary exposure of medical personnel to toxic materials under biochemical hazard conditions. Exposure to a toxin, namely, lipopolysaccharide,[@bib10] was determined by linear discriminant analysis using non-contact derived variables in an animal experiment.[@bib5] In a previous study, we assessed the performance of the newly developed non-contact screening system in a laboratory from an engineering viewpoint.[@bib11] In the present paper, for seasonal influenza (2008--2009) patients and normal control subjects, we investigate whether the newly developed screening system can distinguish influenza patients from normal control subjects at the Japan Self-defense Forces Central Hospital.

Materials and methods {#sec2}
=====================

Non-contact screening system for medical inspection {#sec2.1}
---------------------------------------------------

The technical details of the non-contact screening system have been reported in a previous paper.[@bib11] The non-contact screening system simultaneously measures heart rate, respiratory rate, and facial temperature ([Figure 2](#fig2){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"} ). The non-contact monitoring system consists of a non-contact laser Doppler blood-flow meter (ALF21N, Advance, Tokyo), a prototype 10-GHz respiration radar (Tau-giken, Yokohama, Japan), an infrared thermograph (NEC SANEI, IS7800, Tokyo), and a personal computer with a data processing display program. The Doppler laser probe is used to measure the palmar pulse. The respiratory rate was measured using the 10-GHz respiration radar by monitoring the abdominal respiratory motion, and the facial surface temperature was measured via infrared thermography. The thermography was placed 200 cm from the face of the subject.Figure 1The system is operated by a screening program via a linear discriminant analysis using non-contact derived variables, i.e., palmar pulse determined using a laser Doppler blood-flow meter, respiration rate determined using a 10-GHz microwave radar, and average facial temperature measured by thermography.Figure 2(a) The laser Doppler blood-flow meter output includes cyclic oscillations that are attributed to the palmar pulse of the subject. (b) The 10-GHz microwave radar output includes cyclic oscillations induced by the respiratory motion of the abdomen of the subject.Figure 3The screening system automatically captures the facial area and calculates the average facial temperature of the area within the red rectangle, excluding the facial background area.Figure 4The heart rates of influenza patients are significantly larger than that of the normal control subjects (*p* \< 0.001) (left). The respiratory rates of influenza patients are higher than those of the normal control subjects (*p* \< 0.001) (middle). The average facial temperatures of influenza patients are also significantly larger than those of the normal control subjects (*p* \< 0.001) (right).

We designed a cylindrical post for monitoring vital signs (CPV) (diameter: 22 cm, height: 110 cm) with a disk-shaped plastic cover on top ([Fig. 1](#fig1){ref-type="fig"}). The CPV incorporates a Doppler laser probe for palmar pulse measurement and a 10-GHz respiration radar ([Fig. 1](#fig1){ref-type="fig"}). The heart and respiratory rates and the facial temperature are measured simultaneously while the subject holds his/her left palm over the CPV for 30 s.

The outputs of the laser Doppler blood-flow meter, the respiration radar, and the infrared thermography were transferred to a personal computer and then analyzed and displayed in real time, using the screening program. The screening program incorporates band pass filters for monitoring respiratory and heart rates in order to eliminate background noise. The heart rate is obtained by fast Fourier transform (FFT), and the respiratory rate is determined by the respiration curve measured by the respiration radar. The pulse wave, the respiratory curve, and the thermograph are displayed in real time on a graphic terminal. The screening program calculates average facial temperature and displays the screening result ("potential infection" or "pass") obtained by a linear discriminant function from the non-contact derived heart rate, the respiratory rate, and the average facial temperature.

Testing of the non-contact screening system at a hospital to distinguish influenza patients from normal control subjects {#sec2.2}
------------------------------------------------------------------------------------------------------------------------

The subjects of the present study were 57 patients admitted with headache, sore throat, and other symptoms from January to March, 2009. The patients were diagnosed to have seasonal influenza based on results obtained using QuickVue Rapid SP influ kits (Quidel Corp., USA). These patients were mainly men (86.0%) and were all Self-Defense Forces members. The average age of the patients was 25 years (19--40 years). All influenza patients were treated with an Oseltamivir or a Zanamivir hydrate, and their axillary temperatures averaged 37.0 ± 0.6 °C (35.7 °C ≤ body temperature ≤ 38.3 °C) after hospitalization.

35 Normal control subjects (30 male and five female) were students at the Institute of Medical Radiology Technologists at the Japan Self-Defense Force Central Hospital. These subjects had no symptoms of fever, headache, or sore throat. The average age of the subjects was 26 years (20--35 years). Their axillary temperatures averaged 36.6 ± 0.3 °C (35.5 °C ≤ body temperature ≤ 36.9 °C).

Measurements using the screening system were performed at 10:00--11:00 a.m. for the above hospitalized influenza patients and normal control subjects. The heart rate, respiratory rate, and average facial temperature of each subject were determined using the screening system. The axillary temperatures were measured using a clinical thermometer (Omron MC-107BW) for both influenza patients and normal control subjects. All subjects who normally wore eyeglasses removed them for the facial temperature measurements.

In order to assess the possibility of distinguishing between influenza-infected subjects and normal control subjects, a linear discriminant function was determined using non-contact derived data. Linear discriminant analysis is generally used for data classification. In our previous paper, the exposure to a toxin was determined by linear discriminant analysis using non-contact derived variables in a laboratory experiment, an *F*-test was used to evaluate the significance of the linear discriminant function, which can predict group membership for *p* \< 0.05.[@bib5]

The linear equation was defined as follows:$$Z\left( {x_{1},x_{2},x_{3}} \right) = A + B_{1}X_{1} + \ B_{2}X_{2} + B_{3}X_{3}$$where *Z*(*X* ~1~,*X* ~2,~ *X* ~3~) is a linear discriminant function, *A* is a constant, *B* ~1~, *B* ~2~, and *B* ~3~ are regression coefficients corresponding to the heart rate, the respiratory rate, and the average facial temperature, respectively, and *X* ~1~, *X* ~2~, and *X* ~3~ are variables representing heart rate, respiratory rate, and average facial temperature, respectively.

The optimum combinations of regression coefficients and the constant (*A*) were determined by StatMate III (ATMS, Tokyo) statistical software using the variables derived by the non-contact screening system. We evaluated whether the calculated *Z*(*X* ~1~,*X* ~2~,*X* ~3~) function can discriminant influenza patients from normal control subjects. Mahalanobis D^2^ and the classification error rate were calculated from the non-contact derived variables, where D^2^ is an index of the extent to which the discriminant function discriminants between criterion groups.

Quantitative data are expressed as mean values ± SDs. Statistical analysis was performed using StatMate III (ATMS, Tokyo) software.

Ethical approval {#sec2.3}
----------------

The present study was approved by the Ethics Committee of Japan Self-defense Forces Central Hospital.

Results {#sec3}
=======

Measurements were taken while each subject stood holding the left palm over the top of the CPV. The Doppler laser output exhibits a cyclic oscillation induced by cardiac oscillation with a period of 0.53 s ([Fig. 2](#fig2){ref-type="fig"}(a)). A respiratory oscillation having a period of 3.8 s was observed using a 10-GHz radar ([Fig. 2](#fig2){ref-type="fig"}(b)).

The screening system automatically captures the facial area and calculates the average facial temperature of the area within the red rectangle ([Fig. 3](#fig3){ref-type="fig"}) which includes part of neck, excluding the facial background area (dark blue part f the collar which corresponds to the area temperature \< 30 °C), was calculated.

The average heart rate was 66 ± 10 bpm for normal control subjects and 90 ± 12 bpm for influenza patients, which is significantly larger than that of normal control subjects (*p* \< 0.001) ([Fig. 4](#fig4){ref-type="fig"}, left panel). The average respiratory rate was 13 ± 2 bpm for normal control subjects and 16 ± 3 bpm for influenza patients, which is significantly larger than that of the normal control subjects (*p* \< 0.001) ([Fig. 4](#fig4){ref-type="fig"}, center panel). The average facial temperature was 32.9 ± 0.3 °C for normal control subjects and 33.3 ± 0.7 °C for influenza patients, which is significantly larger than that of the normal control subjects (*p* \< 0.001) ([Fig. 4](#fig4){ref-type="fig"}, right panel).

In order to distinguish the influenza patients group from the normal control subjects group, the *Z*(*X* ~1~,*X* ~2~,*X* ~3~) function was calculated by statistical software (StatMate III) using non-contact derived data, which is shown in part in [Table 1](#tbl1){ref-type="table"} . The derived *Z*(*X* ~1~,*X* ~2~,*X* ~3~) is a statistically significant function (*p* \< 0.001, as determined by an *F*-test):$$Z\left( {X_{1},X_{2},X_{3}} \right) = 35.5 - 0.21X_{1} - 0.48X_{2} - 0.36X_{3}$$where *X* ~1~ is the heart rate, *X* ~2~ is the respiratory rate, and *X* ~3~ is the average facial temperature.Table 1*Z* values of the normal group and the influenza group as calculated from data, which is shown in part in this table (heart rate, respiratory rate, and average facial temperature) using linear discriminant analysis. All *Z* values are positive in the normal group and are negative in the influenza group. The linear discriminant function *Z*(*X*~1~,*X*~2~,*X*~3~) calculated from the non-contact derived variables distinguishes the influenza group from the normal control group. The *Z* value remains effective in distinguishing influenza patients regardless of their temperatures (Cf, gray areas), influenza patients without fever indicate relatively high heart and respiratory rates compared with normal controls within the same body temperature range.

The *Z* values calculated by this formula are shown in part in [Table 1](#tbl1){ref-type="table"}. In this table, *Z* values were positive in the normal control subjects group (left) and negative in the influenza group (right), although some influenza patients have lower average facial temperatures compared to some of the normal subjects, because their relatively high heart and respiratory rates compensate for these average facial temperature inversions. The sign of the *Z* value can be used to distinguish the influenza group from the normal control group. The Mahalanobis D^2^ calculated from the non-contact derived variables was 6.5. The classification error rate corresponding to the Mahalanobis D^2^ was more than 10%.

A total of 51 influenza patients, bounded by the solid line ellipse in [Fig. 5](#fig5){ref-type="fig"} , indicated a negative *Z* value, six influenza patients showed a positive *Z* value, and the corresponding positive predictive value (PPV) and sensitivity are 93% and 88%, respectively. The *Z* value remains effective in distinguishing influenza patients regardless of their temperatures as indicated in [Fig. 5](#fig5){ref-type="fig"}. A total of 30 normal control subjects, bounded by the dotted line ellipse in [Fig. 5](#fig5){ref-type="fig"} indicated a positive *Z* value, and five normal control subjects showed negative *Z* values. The corresponding negative predictive value (NPV) and specificity are 82% and 89%, respectively.Figure 5A total of 51 influenza patients, bounded by the solid line ellipse, had negative *Z* values, and six influenza patients had positive *Z* values. The positive predictive value (PPV) and sensitivity are 93% and 88%, respectively. A total 30 normal control subjects, bounded by the dotted line ellipse, had positive *Z* values, and five normal control subjects had negative *Z* values. The negative predictive value (NPV) and specificity are 82% and 89%, respectively.

The execution screen of the non-contact screening system displays the screening result, i.e., "potential infection" or "pass", which is judged by the sign of the non-contact derived *Z* value ([Fig. 6](#fig6){ref-type="fig"} ).Figure 6Screenshot of an individual being analyzed using the non-contact screening system. The heart and respiratory curves, the facial temperature mapping, and the screening result, i.e., "potential infection" or "pass", are displayed.

Discussions {#sec4}
===========

Some previous studies pointed out that there are many variables that can affect the accuracy of mass screening systems using only thermography. Ambient temperature, heavy makeup, alcohol and perspiration are some examples of such varaiables.[@bib12], [@bib13], [@bib14] However, this non-contact screening system monitors not only temperature but also heart and respiratory rates. In this sense, it may offer an increase in accuracy in detecting infected individuals.

The influenza patients who were the subjects of the present study were treated with an Oseltamivir or a Zanamivir hydrate, and some of them had normal temperatures after medication. The newly developed non-contact screening system using discriminant function is effective in distinguishing influenza patients regardless of their temperatures. This can be attributed to the fact that even in the cases of influenza patients with normal temperatures, their heart and respiratory rates are relatively high compared with normal subjects.

The non-contact screening system showed the PPV of 93%, which is higher than the reported PPV in the recent summary of the existing studies on fever screening using only non-contact infrared thermometers performed mainly in hospitals (the PPV varied from 3.5% to 65.4%).[@bib11] It must be noted, however, in this "case-control" study, the percentage of febrile subject is 26% which is much higher than actual febrile patients percentages. The prevalence of a disease influences PPV, therefore, a larger scale study needs to be conducted. Also, in order to conduct more accurate screening, it is necessary to accumulate data for people of a variety of ages, races, body morphologies, and anamnesis.

In summary, the discriminant function of this proposed system is effective in distinguishing influenza patients regardless of their temperatures, which enables higher PPV rate of 93% compared to the conventional method using only thermography. There are some limitations in detecting infected individuals before symptoms appear. However, the system saves time and effort for screening at airport quarantines and other mass gathering places and contributes to reduce the risk of secondary exposure and transmission of infection.
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